Chengdu Wesley’s New Hemodialysis Consumables Factory Inauguration
On October 15, 2023, Chengdu Wesley celebrated the grand opening of its new production facility in the Sichuan Meishan Pharmaceutical Valley Industrial Park. This state-of-the-art factory marks a significant milestone for the Sanxin company as it establishes its western production base dedicated to the manufacturing of hemodialysis consumables.
The new facility is designed to enhance the quality and efficiency of dialysis disposables, driven by Sanxin’s commitment to high-value product development in the dialysis consumables sector. This strategic move aligns with Chengdu Wesley’s vision of creating an innovative blood purification devices industry chain, contributing to the high-quality development of hemodialysis in China.
One of the most notable achievements of the new factory is the recent acquisition of the wet membrane dialyzer registration certificate. This breakthrough effectively ends the long-standing monopoly of imports in the Chinese market. This development not only enhances the company’s competitive edge but also supports the national goal of achieving self-sufficiency in critical medical supplies.
The Sanxin company is committed to its core values of pragmatism, innovation, cooperation, and win-win. As its subsidiary, Chengdu Wesley aims to embody the spirit of innovators and hard workers as it focuses on becoming a leading one-stop solution provider in the dialysis industry worldwide. By continuously strengthening its core competencies in hemodialysis equipment, we are poised to extend our industrial chain and enhance our market presence.
The new factory is also a testament to the company’s digital transformation. With plans to implement “5G + Smart Factory” initiatives, Chengdu Wesley aims to leverage cutting-edge technology to optimize production processes, improve product quality, and enhance operational efficiency.
With a focus on enhancing local production capabilities and embracing digital transformation, Chengdu Wesley is well-positioned to lead the blood purification industry in China.
Post time: Oct-29-2024